Clinical Trial

Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells

Study acronym: TORCH
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to understand how cells of the immune system use the common sugar glucose to fuel energy production and as a building block within the cell. Investigators will intravenously infuse a non-radioactive glucose tracer into participants over a few hours and collect immune cells from the blood to track uptake and usage of this glucose within these immune cells.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-04-08; most recent amendment 2025-11-01.
Status change: Not Yet Recruiting → Recruiting 2025-10-15
Trial Details
NCT Number NCT06930976
Lead Sponsor Vanderbilt University Medical Center
Conditions Glucose, Metabolism, Isotope Labeling, Immune System and Related Disorders
Enrollment 12 participants
Start Date 2025-10-01
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-04